AMGEN ANNOUNCES NEW OTEZLA (APREMILAST) DATA AT AAD CONGRESS 2022
/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that new Otezla (apremilast) data, along with findings on the unmet need for patients with plaque...
Source: prnewswire.com
Subgroup Analysis Stratified News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Subgroup Analysis Stratified. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Subgroup Analysis Stratified Today - Breaking & Trending Today